Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells

British Journal of Cancer

Volumn 94, Issue 1, 2006, Pages 93-100

  Panetta, J C ^a,b   Evans, W E ^a,b   Cheok, M H ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cell cycle; Mathematical model; Mercaptopurine

Indexed keywords

DNA; MERCAPTOPURINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL CYCLE S PHASE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DNA REPAIR; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MATHEMATICAL MODEL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TIME;

6-MERCAPTOPURINE; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL CYCLE; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MODELS, THEORETICAL; TUMOR CELLS, CULTURED;

EID: 30644465348     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602893     Document Type: Article

References (17)

1. Cheok MH, Yang W, Pui CH, Downing JR, Cheng C, Naeve CW, Relling MV, Evans WE (2003) Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nat Genet 34: 85-90
2. D'Argenio DZ, Schumitzky A (1997) ADAPT II User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software (Report). Los Angeles: Biomedical Simulations Resource
3. Dervieux T, Blanco JG, Krynetski EY, Vanin EF, Roussel MF, Relling MV (2001) Differing contribution of thiopurine methyltransferase to mercaptopurine vs thioguanine effects in human leukemic cells. Cancer Res 61: 5810-5816
4. Dervieux T, Chu Y, Su Y, Pui CH, Evans WE, Relling MV (2002) HPLC determination of thiopurine nucleosides and nucleotides in vivo in lymphoblasts following mercaptopurine therapy. Clin Chem 48: 61-68
5. Kozusko F, Chen P, Grant SG, Day BW, Panetta JC (2001) A mathematical model of in vitro cancer cell growth and treatment with the antimitotic agent curacin A. Math Biosci 170: 1-16
6. Krynetskaia NF, Brenner TL, Krynetski EY, Du W, Panetta JC, Ching-Hon P, Evans WE (2003) Msh2 deficiency attenuates but does not abolish thiopurine hematopoietic toxicity in msh2-/- mice. Mol Pharmacol 64: 456-465
7. Krynetskaia NF, Cai X, Nitiss JL, Krynetski EY, Relling MV (2000) Thioguanine substitution alters DNA cleavage mediated by topoisomerase II. FASEB J 14: 2339-2344
8. Krynetskaia NF, Krynetski EY, Evans WE (1999) Human RNase H-mediated RNA cleavage from DNA-RNA duplexes is inhibited by 6-deoxythioguanosine incorporation into DNA. Mol Pharmacol 56: 841-848
9. Krynetski EY, Krynetskaia NF, Bianchi ME, Evans WE (2003) A nuclear protein complex containing high mobility group proteins B1 and B2, heat shock cognate protein 70, ERp60, and glyceraldehyde-3-phosphate dehydrogenase is involved in the cytotoxic response to DNA modified by incorporation of anticancer nucleoside analogues. Cancer Res 63: 100-106
10. Ling YH, Chan JY, Beattie KL, Nelson JA (1992) Consequences of 6-thioguanine incorporation into DNA on polymerase, ligase, and endonuclease reactions. Mol Pharmacol 42: 802-807
11. Maybaum J, Mandel HG (1983) Unilateral chromatid damage: a new basis for 6-thioguanine cytotoxicity. Cancer Res 43: 3852-3856
12. Offman J, Opelz G, Doehler B, Cummins D, Halil O, Banner NR, Burke MM, Sullivan D, Macpherson P, Karran P (2004) Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. Blood 104: 822-828
13. Reid G, Wielinga P, Zelcer N, De Haas M, Van Deemter L, Wijnholds J, Balzarini J, Borst P (2003) Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol Pharmacol 63: 1094-1103
14. Relling MV, Hancock ML, Boyett JM, Pui CH, Evans WE (1999) Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 93: 2817-2823
15. Somerville L, Krynetski EY, Krynetskaia NF, Beger RD, Zhang W, Marhefka CA, Evans WE, Kriwacki RW (2003) Structure and dynamics of thioguanine-modified duplex DNA. J Biol Chem 278: 1005-1011
16. Waters TR, Swann PF (1997) Cytotoxic mechanism of 6-thioguanine: hMutSalpha, the human mismatch binding heterodimer, binds to DNA containing S6-methylthioguanine. Biochemistry (Mosc) 36: 2501-2506
17. Zeng H, Lin ZP, Sartorelli AC (2004) Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06. Biochem Pharmacol 68: 911-921